Skip to main
KRON
KRON logo

Kronos Bio Inc (KRON)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy KRON Stock

About Kronos Bio Inc (KRON)

Kronos Bio, Inc. is a clinical development biopharmaceutical company. It engages in the business of developing therapeutics that target dysregulated transcription that causes cancer and other serious diseases. The company was founded by Arie S. Belldegrun, Joshua A. Kazam, David M. Tanen, and Christopher Wilfong on June 2, 2017 and is headquartered in San Mateo, CA.
Market cap$54.42M
Today's volume347.77K
Revenue (TTM)$9.19M
Avg. daily volume767.34K
EBITDA (TTM)-$49.01M
Open$0.88
Price / earnings ratio-0.84x
Today's range$0.88 - $0.9
Debt / equity30.18x
52 week range$0.65 - $1.6
5 year debt / equity13.62x
Beta (LTM)0.35x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio12.93x
Ex-dividend date
Next earningsJun 27, 2025
Dividend payable date

KRON Stock Rating

What analysts recommend for KRON stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 75%
Buy 0%
Hold 25%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for KRON stock is $54.43M

The current P/E ratio for KRON stock is -0.84

The 52-week high for KRON stock is $1.60. The current KRON stock price $undefined is 100.00% below its 52-week high

The 52-week low for KRON stock is $0.65. The current KRON stock price $undefined has increased 100.00% from its 52-week low

No, the KRON stock does not pay dividends to its shareholders

The target price for KRON stock is $7.31 based on the average of what a group of analyst think KRON stock could be worth at a future date. This is not a prediction by Public.com

How to buy KRON stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in KRON stock

    Navigate to the Explore page. Then, type KRON into the search bar. When you see KRON stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased KRON stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Kronos Bio Inc Stock Earnings

The value each KRON share was expected to gain vs. the value that each KRON share actually gained.

KRON (KRON) reported Q4 2024 earnings per share (EPS) of -$0.43, missing estimates of -$0.30 by 43.33%. In the same quarter last year, KRON's earnings per share (EPS) was -$0.43. KRON is expected to release next earnings on 06/27/2025, with an earnings per share (EPS) estimate of $0.

Buy KRON Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.